Huons Meditech Targets Southeast Asia Market at 'AMUSE 2026' in Indonesia

- Promotes aesthetic medical devices including ‘Dermashine Duo_RF’ -

▲ Huons Meditech recently participated in ‘AMUSE 2026,’ a premier international scientific congress held in Indonesia. On the photo, a representative of Huons Meditech is presenting ‘Dermashine Duo_RF’ to the participants.

Huons Meditech, a medical device subsidiary of Huons Group, showcased its technological prowess and competitive edge at ‘AMUSE 2026,’ one of the region’s premier and fastest-growing international scientific congresses for aesthetic medicine.

Huons Meditech (CEO Changwoo Ha) announced on the 16th that it participated in ‘AMUSE 2026,’ which took place from June 12 to 14 in Jakarta, Indonesia. 

AMUSE is a premier, multidisciplinary congress for medical aesthetics, plastic surgery, and dermatology in Indonesia. The event takes place annually at the Indonesia Convention Exhibition (ICE BSD City) and attracts thousands of medical professionals. Through this exhibition, Huons Meditech aimed to strengthen its presence in the Southeast Asia market by showcasing its flagship medical device lineup—‘Dermashine Duo_RF’ and ‘Premium 9-Pin Needle’

During AMUSE 2026, the company highlighted its flagship aesthetic device, ‘Dermashine Duo_RF’, a device that combines precise drug delivery with radiofrequency (RF) technology, which has received approval in Indonesia.

‘Dermashine Duo_RF’ is compatible with a range of needle tips, including 31G, 32G and 34G, allowing the device to support various injection needs. It is optimized for the delivery of high-viscosity polymer skin boosters such as polynucleotide (PN), poly-L-lactic acid (PLLA), poly-D-lactic acid (PDLA), and polycaprolactone (PCL). By incorporating an enhanced pressure-sensing automatic injection system, the device helps reduce pain and provides a safer, more comfortable treatment experience, while also minimizing drug loss during the injection process. 

The ‘Premium 9-Pin Needle,’ which also obtained approval in Indonesia, is a dedicated disposable microneedle for skin booster injections. The needle features a laser-marked rotary controller that allows precise depth adjustment. Furthermore, it optimizes the bevel angle and length to minimize drug leakage during the procedure and reduce patient pain.

CEO of Huons Meditech, Changwoo Ha stated, "Participating in AMUSE, Indonesia’s most interactive international scientific congress, and introducing the proven safety and efficacy of 'Dermashine Duo_RF' to the Southeast Asia market is highly significant. This exhibition provided an opportunity to widely promote our technological capabilities and product excellence in the Southeast Asia market and to strengthen our collaborative relationships with local partners."